Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs in Denmark and internationally. The company operates through CRO, Discovery & Partnerships, and Gubra Green segments. It offers pre-clinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, assays and molecular pharmacology, bioinformatics, bioanalysis, next gen sequencing, and 2D and 3D imaging. The company has a partnership and collaboration with Boehringer Ingelheim to discover novel peptides for the treatment of obesity. Gubra A/S was incorporated in 2008 and is based in Horsholm, Denmark.
तुलना करने के लिए मीट्रिक्स | GUBRA | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधGUBRAपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | −253.1x | −1.8x | −0.7x | |
PEG अनुपात | 0.61 | 0.02 | 0.00 | |
क़ीमत/बुक | 25.4x | 2.6x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 52.6x | 3.3x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 18.6% | 43.2% | |
उचित मूल्य अपसाइड | अनलॉक करें | 9.7% | 6.8% | अनलॉक करें |